Proviruses
-
Subject Areas on Research
- A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.
- A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.
- A computational framework to assess genome-wide distribution of polymorphic human endogenous retrovirus-K In human populations.
- AIDS. Where has HIV been hiding?
- Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor.
- Activation of tat-defective human immunodeficiency virus by ultraviolet light.
- Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.
- Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease.
- Amplification of human immunodeficiency virus provirus from cerebrospinal fluid: results of long-term clinical follow-up.
- Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.
- Derivation of a biologically contained replication system for human immunodeficiency virus type 1.
- Detection of HIV-2 by PCR.
- Development and characterization of an Fv-1-sensitive retrovirus-packaging system: single-hit titration kinetics observed in restrictive cells.
- Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate.
- Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.
- Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
- Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV(89.6).
- Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity.
- Group II introns designed to insert into therapeutically relevant DNA target sites in human cells.
- HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses.
- HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells.
- High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
- Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
- Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.
- Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.
- Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
- Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
- Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.
- Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.
- Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.
- Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B.
- Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
- Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.
- Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.
- Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1.
- Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.
- Patterns of HIV-1 mRNA expression in transgenic mice are tissue-dependent.
- Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
- Reduction of peak viremia by an integration-defective SIV proviral DNA vaccine in rhesus macaques.
- Regulation of human immunodeficiency virus replication.
- Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity.
- Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency.
- Tax Induces the Recruitment of NF-κB to Unintegrated HIV-1 DNA To Rescue Viral Gene Expression and Replication.
- The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.
- Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
- Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.